• In May 2026, DXC Technology reported quarterly results showing lower year-on-year sales and a net loss, issued softer revenue guidance for fiscal 2027 of about US$12.11 billion to US$12.35 billion, and disclosed completion of a share repurchase program totaling US$658.10 million for 36,148,671 shares.
• Amid these challenges, DXC also extended its long-running partnership with BAE Systems for five years to deliver an AI-enabled hybrid cloud platform for more than 110,000 employees, underscoring its continued role in complex, security-sensitive digital transformation projects.
• We’ll now examine how weaker sales guidance, alongside the extended BAE Systems AI-enabled cloud partnership, could reshape DXC Technology’s investment narrative.

AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

DXC Technology Investment Narrative Recap

To own DXC Technology today, you need to believe it can turn weak sales and thin profitability into a more resilient, AI- and cloud-led services business. The immediate catalyst remains management’s ability to stabilize organic revenue and restore earnings credibility, while the biggest risk is that ongoing revenue declines and margin pressure become entrenched. The latest guidance reset and net loss are material here, as they highlight how much execution work still lies ahead.

Against that backdrop, the five-year extension with BAE Systems for an AI-enabled hybrid cloud platform stands out. It reinforces DXC’s relevance in large, complex, security-sensitive projects at a time when its top line is under pressure. For investors focused on catalysts, this kind of long-duration, high-complexity engagement can help support the case that DXC still has a seat at the table in high-value digital transformation work, even as revenue guidance softens.

Yet beneath these headline contracts, investors should also be aware that ongoing organic revenue declines and execution challenges could still...

DXC Technology’s narrative projects $12.1 billion revenue and $208.6 million earnings by 2028. This implies a 1.7% yearly revenue decline and an earnings decrease of $170.4 million from $379.0 million today.

Uncover how DXC Technology's forecasts yield a $14.50 fair value, a 62% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts still projected revenue near US$12.2 billion and shrinking margins, so if you lean on that more upbeat view, it now sits in sharp contrast to weaker guidance and highlights how differently you and others might assess DXC’s contract wins and revenue risks.

Explore 3 other fair value estimates on DXC Technology - why the stock might be worth just $14.50!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your DXC Technology research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free DXC Technology research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate DXC Technology's overall financial health at a glance.

Ready For A Different Approach?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• The latest GPUs need a type of rare earth metal called Terbium and there are only 28 companies in the world exploring or producing it. Find the list for free.
• Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.